Rekvina Labs Ltd

Rekvina Labs Limited, a micro-cap pharmaceutical contract manufacturer with a market capitalisation of ₹20.00 crores, reported a net loss of ₹0.06 crores for Q4 FY26 (Mar'26), marking a 50.00% reduction in losses compared to the previous quarter's ₹0.12 crores loss. Whilst the company demonstrated sequential revenue growth of 105.71% to reach ₹0.72 crores in Q4 FY26, the persistent inability to achieve profitability and negative operating margins continue to raise serious concerns about the viability of its business model.

Rekvina Labs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 May 2026, providing investors with the latest insights into the company’s performance and outlook.

With a sustained four-day rally culminating in a fresh 52-week high of Rs 46.65 on 27 Apr 2026, Rekvina Labs Ltd has demonstrated remarkable price momentum, trading well above all key moving averages and signalling robust technical health despite a modest underperformance relative to its sector today.

With a decisive break above Rs 45.74 on 24 Apr 2026, Rekvina Labs Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum despite a broadly weakening market backdrop.

With every major technical indicator aligned to the upside, Rekvina Labs Ltd surged to a fresh 52-week high of Rs 44.85 on 23 Apr 2026, marking a significant milestone in its price momentum after a steady two-day gain of 4.01%.

With a sustained nine-day rally delivering a 19.38% gain, Rekvina Labs Ltd surged to a fresh 52-week high of Rs 43.99 on 20 Apr 2026, marking a significant milestone in its price momentum.

With a sustained rally over the past eight trading sessions, Rekvina Labs Ltd has surged 17.04% to touch a new 52-week high of Rs 43.13 on 17 Apr 2026, marking a significant milestone from its 52-week low of Rs 6.75. This price momentum is underpinned by a confluence of bullish technical indicators across multiple timeframes, signalling robust upward momentum.

Rekvina Labs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

With a sustained seven-day rally culminating in a 14.76% gain, Rekvina Labs Ltd surged to a fresh 52-week high of Rs 42.29 on 16 Apr 2026, outperforming its sector by nearly 2%. This milestone caps a remarkable ascent from its 52-week low of Rs 6.75, underscoring a powerful momentum shift in the stock’s price action.

Surging past its previous peaks, Rekvina Labs Ltd touched a fresh 52-week high of Rs 41.47 on 15 Apr 2026, propelled by a sustained six-day rally that has delivered a 12.54% gain. This milestone caps a remarkable price journey from a low of Rs 6.75 in the past year, underscoring a powerful momentum shift in the stock’s technical landscape.

With a decisive break above Rs 40.66 on 13 Apr 2026, Rekvina Labs Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum over the past week.

Surging past its previous peaks, Rekvina Labs Ltd reached a new 52-week high of Rs 39.87 on 10 Apr 2026, propelled by a confluence of bullish technical indicators and sustained price momentum over recent sessions.

With a decisive break above Rs 39.09 on 9 Apr 2026, Rekvina Labs Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum despite a broadly weakening market backdrop.

With a sustained rally over the past 15 trading sessions, Rekvina Labs Ltd has surged to a fresh 52-week high of Rs 38.35 on 6 Apr 2026, marking a remarkable 33.34% gain during this period. This price milestone is underscored by a confluence of bullish technical indicators that highlight strong momentum despite a broadly weakening market backdrop.

From a low of Rs 6.75 to a fresh peak of Rs 37.6, Rekvina Labs Ltd has surged over 450% in the past year, defying the broader market's downward trend. This remarkable rally is underpinned by a confluence of bullish technical indicators and sustained price momentum, marking a significant milestone for the micro-cap stock.

After a sustained rally over the past 13 trading sessions, Rekvina Labs Ltd has surged to a fresh 52-week high of Rs 36.87 on 1 Apr 2026, marking a remarkable 28.2% gain during this period. This milestone comes amid a broader market environment where the Sensex has been under pressure, highlighting the stock’s distinctive momentum.

Surging past its previous peaks, Rekvina Labs Ltd touched a fresh 52-week high of Rs 36.15 on 30 Mar 2026, marking a remarkable rally from its 52-week low of Rs 6.75. This breakout is underscored by a sustained 12-day winning streak and a 25.7% return over this period, signalling robust price momentum despite a broadly subdued market backdrop.

After a sustained rally spanning 11 consecutive trading sessions, Rekvina Labs Ltd surged to a fresh 52-week high of Rs 35.54 on 27 Mar 2026, marking a remarkable turnaround from its 52-week low of Rs 6.75. This price milestone is underpinned by a confluence of bullish technical indicators and robust price momentum, even as the broader market struggles with bearish undertones.